NASDAQ:STEX Biosig Technologies (STEX) Stock Price, News & Analysis $0.76 +0.00 (+0.33%) Closing price 07/23/2026 04:00 PM EasternExtended Trading$0.78 +0.02 (+2.23%) As of 07/23/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock About Biosig Technologies Stock (NASDAQ:STEX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Biosig Technologies alerts:Sign Up Key Stats Today's Range$0.76▼$0.8450-Day Range$0.74▼$1.5152-Week Range$0.70▼$7.44Volume845,890 shsAverage Volume1.84 million shsMarket Capitalization$138.90 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company Overview Biosig Technologies (NASDAQ:STEX) is a medical technology company focused on developing advanced signal acquisition and processing solutions for cardiac electrophysiology. The company’s work centers on improving the clarity and interpretability of intracardiac signals captured during electrophysiology procedures, with the goal of helping clinicians identify arrhythmogenic substrates and make more informed procedural decisions. Its primary offering is a signal-processing platform that combines proprietary hardware and software to amplify, filter and display intracardiac electrical activity with reduced noise and distortion. The technology is intended to integrate with existing electrophysiology lab equipment and workflows, supporting procedures such as ablations used to treat atrial fibrillation and other arrhythmias. By enhancing signal fidelity, the company aims to support procedural efficiency and clinical decision-making for electrophysiologists and hospital electrophysiology labs. Biosig positions its product development around clinical validation and regulatory pathways common to medical device commercialization, and it targets adoption by hospitals, specialty clinics and physician groups that perform invasive cardiac electrophysiology procedures. The company pursues clinical studies and collaborations to demonstrate the clinical utility of its technology and to support broader commercialization within the medical community. AI Generated. May Contain Errors. Read More Biosig Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreSTEX MarketRank™: Biosig Technologies scored higher than 63% of companies evaluated by MarketBeat, and ranked 29th out of 91 stocks in the manufacturing sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingBiosig Technologies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialBiosig Technologies has a consensus price target of $8.00, representing about 947.1% upside from its current price of $0.76.Amount of Analyst CoverageBiosig Technologies has only been the subject of 2 research reports in the past 90 days.Read more about Biosig Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Biosig Technologies is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Biosig Technologies is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBiosig Technologies has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.67% of the float of Biosig Technologies has been sold short.Short Interest Ratio / Days to CoverBiosig Technologies has a short interest ratio ("days to cover") of 6.01.Change versus previous monthShort interest in Biosig Technologies has recently decreased by 4.12%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBiosig Technologies does not currently pay a dividend.Dividend GrowthBiosig Technologies does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.40 News SentimentBiosig Technologies has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Manufacturing companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Biosig Technologies this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for STEX on MarketBeat in the last 30 days. This is a decrease of -90% compared to the previous 30 days.MarketBeat Follows5 people have added Biosig Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership3.7 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $18,908.00 in company stock, which represents 0.0136% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Biosig Technologies insiders have bought 8.10% more of their company's stock than they have sold. Specifically, they have bought $252,360.00 in company stock and sold $233,452.00 in company stock.Percentage Held by Insiders52.73% of the stock of Biosig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions7.16% of the stock of Biosig Technologies is held by institutions.Read more about Biosig Technologies' insider trading history. Receive STEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biosig Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. STEX Stock News HeadlinesStreamex Corp. Details GLDY's Liquidity Infrastructure; ~$12 Million in Seeded Liquidity Supports 24/7, 365 Instant Trading Across Multiple Institutional-Grade VenuesJuly 23 at 7:30 AM | globenewswire.comStreamex Corp. Announces 24/7, 365 Instant Liquidity for GLDY Through Collaboration with WintermuteJuly 23 at 7:00 AM | globenewswire.comUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income Plan - direct ownership in 14 entities controlling U.S. pipelines, terminals, and processing plants, targeting 10% annually. The plan issues 42 payouts per year and is on pace to distribute $53 billion in 2025 - a record. The next distribution drops in days. | Freedom Financial (Ad)Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance InvestorsJuly 21 at 7:30 AM | globenewswire.comBiosig Technologies (NASDAQ:STEX) & Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Head-To-Head ReviewJuly 20, 2026 | americanbankingnews.comInspira Technologies OXY B.H.N. (NASDAQ:QTEX) versus Biosig Technologies (NASDAQ:STEX) Financial ComparisonJuly 20, 2026 | americanbankingnews.comBiosig Technologies (NASDAQ:STEX) Downgraded to "Strong Sell" Rating by Wall Street ZenJuly 18, 2026 | americanbankingnews.comStreamex Corp. Announces June 2026 Yield Dividend Distribution for GLDYJuly 17, 2026 | globenewswire.comSee More Headlines STEX Stock Analysis - Frequently Asked Questions How have STEX shares performed this year? Biosig Technologies' stock was trading at $3.40 on January 26, 2026. Since then, STEX shares have decreased by 77.5% and is now trading at $0.7640. How were Biosig Technologies' earnings last quarter? Biosig Technologies, Inc. (NASDAQ:STEX) posted its quarterly earnings results on Thursday, May, 14th. The company reported ($0.27) EPS for the quarter. Read the conference call transcript. Is Biosig Technologies doing a stock buyback? Biosig Technologies' board authorized a stock buyback plan on Tuesday, July 7th 2026, which allows the company to buy back 10,000,000,000,000 shares, according to EventVestor. This means that the company could buy up to 5.5% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its shares are undervalued. How do I buy shares of Biosig Technologies? Shares of STEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/14/2026Today7/23/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (9m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 STEX's financial health is in the Yellow zone, according to TradeSmith. STEX has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorManufacturing Industry Surgical, Medical, And Dental Instruments And Supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:STEX CIK1530766 WebN/A Phone(203) 409-5444FaxN/AEmployees50Year Founded2009Price Target and Rating Average Price Target for Biosig Technologies$8.00 High Price Target$8.00 Low Price Target$8.00 Potential Upside/Downside+947.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($9.71) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$462.77 million Net MarginsN/A Pretax MarginN/A Return on Equity-717.92% Return on Assets-336.75% Debt Debt-to-Equity RatioN/A Current Ratio13.90 Quick Ratio13.90 Sales & Book Value Annual Sales$40 thousand Price / Sales3,472.38 Cash FlowN/A Price / Cash FlowN/A Book Value$0.83 per share Price / Book0.92Miscellaneous Outstanding Shares181,800,000Free Float85,939,000Market Cap$138.90 million OptionableN/A Beta1.94 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:STEX) was last updated on 7/24/2026 by MarketBeat.com Staff. From Our PartnersThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredElon's next move will be bigger than the IPO – and it could happen any day nowHedge fund legend Larry Benedict - who delivered a 279% return on cash in 2025 and went on a 20-year winning s...Brownstone Research | SponsoredThe SpaceX IPO Wasn't For YouJust one mile from SpaceX's launchpad sits a small company doing something SpaceX can't - and it still trades ...Freedom Financial | SponsoredA Wall Street Veteran's Weekly Options Strategy ExplainedA former Merrill Lynch and Vanguard advisor spent 25 years watching one weekly options play generate consisten...Base Camp Trading | SponsoredThe $40 billion "side project" Elon buried inside SpaceXElon Musk has been quietly building a $40 billion project inside SpaceX — housed in a converted refrigerator f...The Oxford Club | SponsoredTrump’s $250 Bill – See ImmediatelyFormer Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...Stansberry Research | SponsoredGates. Google. The Pentagon.Bill Gates wrote a $100 million check. Google signed a 15-year contract. The Pentagon named it their top energ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
